Table 1. Non Small Cell Lung Cancer Treatment Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Non Small Cell Lung Cancer Treatment Market Restraints

Table 3. Non Small Cell Lung Cancer Treatment Market Trends

Table 4. Non Small Cell Lung Cancer Treatment Industry Policy

Table 5. Global Non Small Cell Lung Cancer Treatment Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Company (2019-2024)

Table 7. Global Non Small Cell Lung Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Non Small Cell Lung Cancer Treatment Mergers & Acquisitions, Expansion Plans

Table 9. Global Non Small Cell Lung Cancer Treatment Manufacturers Product Type

Table 10. China Non Small Cell Lung Cancer Treatment Revenue by Company (2019-2024) & (US$ million)

Table 11. China Non Small Cell Lung Cancer Treatment Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Non Small Cell Lung Cancer Treatment Upstream (Raw Materials)

Table 13. Global Non Small Cell Lung Cancer Treatment Typical Customers

Table 14. Non Small Cell Lung Cancer Treatment Typical Distributors

Table 15. By Type, Global Non Small Cell Lung Cancer Treatment Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Non Small Cell Lung Cancer Treatment Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Non Small Cell Lung Cancer Treatment Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Non Small Cell Lung Cancer Treatment Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2030

Table 22. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 23. Novartis AG Company Profile and Main Business

Table 24. Novartis AG Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 25. Novartis AG Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 26. Novartis AG Recent Developments

Table 27. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 28. Pfizer Inc Company Profile and Main Business

Table 29. Pfizer Inc Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 30. Pfizer Inc Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 31. Pfizer Inc Recent Developments

Table 32. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 33. Sanofi Company Profile and Main Business

Table 34. Sanofi Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 35. Sanofi Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 36. Sanofi Recent Developments

Table 37. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 38. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 39. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 40. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 41. F. Hoffmann-La Roche Ltd Recent Developments

Table 42. Astrazeneca Company Information, Head Office, Market Area and Industry Position

Table 43. Astrazeneca Company Profile and Main Business

Table 44. Astrazeneca Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 45. Astrazeneca Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 46. Astrazeneca Recent Developments

Table 47. Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position

Table 48. Eli Lilly and Company Company Profile and Main Business

Table 49. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 50. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 51. Eli Lilly and Company Recent Developments

Table 52. Merck & Co Inc Company Information, Head Office, Market Area and Industry Position

Table 53. Merck & Co Inc Company Profile and Main Business

Table 54. Merck & Co Inc Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 55. Merck & Co Inc Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 56. Merck & Co Inc Recent Developments

Table 57. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 58. Bristol-Myers Squibb Company Company Profile and Main Business

Table 59. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 60. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 61. Bristol-Myers Squibb Company Recent Developments

Table 62. Celgene Corporation Company Information, Head Office, Market Area and Industry Position

Table 63. Celgene Corporation Company Profile and Main Business

Table 64. Celgene Corporation Non Small Cell Lung Cancer Treatment Models, Specifications and Application

Table 65. Celgene Corporation Non Small Cell Lung Cancer Treatment Revenue and Gross Margin, 2019-2024

Table 66. Celgene Corporation Recent Developments

List of Figure

Figure 1. Non Small Cell Lung Cancer Treatment Picture

Figure 2. Global Non Small Cell Lung Cancer Treatment Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Non Small Cell Lung Cancer Treatment Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Non Small Cell Lung Cancer Treatment Market Share of Global

Figure 5. Global Non Small Cell Lung Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Non Small Cell Lung Cancer Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Non Small Cell Lung Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Non Small Cell Lung Cancer Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Non Small Cell Lung Cancer Treatment Industry Chain

Figure 10. Chemotherapy

Figure 11. Targeted Therapy

Figure 12. Immunotherapy

Figure 13. By Type, Global Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, US$ Million

Figure 14. By Type, Global Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2030

Figure 15. Hospital

Figure 16. Clinic

Figure 17. Others

Figure 18. By Application, Global Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, US$ Million

Figure 19. By Application, Global Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2030

Figure 20. By Region, Global Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2030

Figure 21. North America Non Small Cell Lung Cancer Treatment Revenue & Forecasts, 2019-2030, US$ Million

Figure 22. By Country, North America Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2024

Figure 23. Europe Non Small Cell Lung Cancer Treatment Revenue & Forecasts, 2019-2030, US$ Million

Figure 24. By Country, Europe Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2024

Figure 25. Asia Pacific Non Small Cell Lung Cancer Treatment Revenue & Forecasts, 2019-2030, US$ Million

Figure 26. By Country/Region, Asia Pacific Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2024

Figure 27. South America Non Small Cell Lung Cancer Treatment Revenue & Forecasts, 2019-2030, US$ Million

Figure 28. By Country, South America Non Small Cell Lung Cancer Treatment Revenue Market Share, 2019-2024

Figure 29. Middle East & Africa Non Small Cell Lung Cancer Treatment Revenue & Forecasts, 2019-2030, US$ Million

Figure 30. U.S. Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 31. By Company, U.S. Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 32. By Type, U.S. Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 34. Europe Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 35. By Company, Europe Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 36. By Type, Europe Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 38. China Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 39. By Company, China Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 40. By Type, China Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 42. Japan Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 43. By Company, Japan Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 44. By Type, Japan Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 47. By Company, South Korea Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 48. By Type, South Korea Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 51. By Company, Southeast Asia Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 52. By Type, Southeast Asia Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 54. India Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 55. By Company, India Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 56. By Type, India Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Non Small Cell Lung Cancer Treatment Revenue, 2019-2030, (US$ Million)

Figure 59. By Company, Middle East & Asia Non Small Cell Lung Cancer Treatment Market Share, 2019-2024

Figure 60. By Type, Middle East & Asia Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Non Small Cell Lung Cancer Treatment Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches